Details
Stereochemistry | RACEMIC |
Molecular Formula | C16H20N2O2 |
Molecular Weight | 272.3422 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(CN1CCCCC1)C2=NOC(=C2)C3=CC=CC=C3
InChI
InChIKey=XKFIQZCHJUUSBA-UHFFFAOYSA-N
InChI=1S/C16H20N2O2/c19-15(12-18-9-5-2-6-10-18)14-11-16(20-17-14)13-7-3-1-4-8-13/h1,3-4,7-8,11,15,19H,2,5-6,9-10,12H2
Molecular Formula | C16H20N2O2 |
Molecular Weight | 272.3422 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/6489869Curator's Comment: Description was created based on several sources, including http://www.drugfuture.com/chemdata/perisoxal.html
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6489869
Curator's Comment: Description was created based on several sources, including http://www.drugfuture.com/chemdata/perisoxal.html
Perisoxal citrate is a basic nonsteroidal anti-inflammatory and analgesic drug.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: http://www.ncbi.nlm.nih.gov/pubmed/397126 |
Palliative | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/7448957
200 mg/man, p. o
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:19:48 GMT 2023
by
admin
on
Fri Dec 15 17:19:48 GMT 2023
|
Record UNII |
H0YBV6N85R
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2055-44-9
Created by
admin on Fri Dec 15 17:19:48 GMT 2023 , Edited by admin on Fri Dec 15 17:19:48 GMT 2023
|
PRIMARY | |||
|
C021233
Created by
admin on Fri Dec 15 17:19:48 GMT 2023 , Edited by admin on Fri Dec 15 17:19:48 GMT 2023
|
PRIMARY | |||
|
SUB09732MIG
Created by
admin on Fri Dec 15 17:19:48 GMT 2023 , Edited by admin on Fri Dec 15 17:19:48 GMT 2023
|
PRIMARY | |||
|
H0YBV6N85R
Created by
admin on Fri Dec 15 17:19:48 GMT 2023 , Edited by admin on Fri Dec 15 17:19:48 GMT 2023
|
PRIMARY | |||
|
C170312
Created by
admin on Fri Dec 15 17:19:48 GMT 2023 , Edited by admin on Fri Dec 15 17:19:48 GMT 2023
|
PRIMARY | |||
|
100000082202
Created by
admin on Fri Dec 15 17:19:48 GMT 2023 , Edited by admin on Fri Dec 15 17:19:48 GMT 2023
|
PRIMARY | |||
|
2110
Created by
admin on Fri Dec 15 17:19:48 GMT 2023 , Edited by admin on Fri Dec 15 17:19:48 GMT 2023
|
PRIMARY | |||
|
DTXSID00860146
Created by
admin on Fri Dec 15 17:19:48 GMT 2023 , Edited by admin on Fri Dec 15 17:19:48 GMT 2023
|
PRIMARY | |||
|
3529
Created by
admin on Fri Dec 15 17:19:48 GMT 2023 , Edited by admin on Fri Dec 15 17:19:48 GMT 2023
|
PRIMARY | |||
|
71109
Created by
admin on Fri Dec 15 17:19:48 GMT 2023 , Edited by admin on Fri Dec 15 17:19:48 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105453
Created by
admin on Fri Dec 15 17:19:48 GMT 2023 , Edited by admin on Fri Dec 15 17:19:48 GMT 2023
|
PRIMARY | |||
|
m1221
Created by
admin on Fri Dec 15 17:19:48 GMT 2023 , Edited by admin on Fri Dec 15 17:19:48 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |